Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Lymphoma, Follicular 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Renal Insufficiency 1Pancreatic Neoplasms 1Lymphoma, B-Cell 1Lung Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 7Nivolumab 3poly ICLC 2durvalumab 2Rituximab 2Gemcitabine 2Capecitabine 2utomilumab 1tremelimumab 1tanespimycin 1mirabegron 1entinostat 1ciforadenant 1cemiplimab 1Vorinostat 1Thalidomide 1Specimen Handling 1SUB1 protein, human 1SRA737 1Ritonavir 1Radiotherapy 1Radiation 1Polymerase Chain Reaction 1Paclitaxel 1Nicotine 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Injections, Subcutaneous 1Indinavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × mirabegron × Lymphoid × Clear all
NCT06534762 2024-08-02

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

Zhejiang Provincial People's Hospital

Phase 2 Recruiting
260 enrolled
BreastGastrointestinalHead & NeckLymphoidSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Lymphoma, B-Cell, Dendritic Cell Sarcoma, Interdigitating, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡